Wolverine Trading’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,100
Closed -$136K 5620
2025
Q2
$136K Buy
+11,100
New +$140K ﹤0.01% 4078
2018
Q4
Sell
-13,100
Closed -$897K 4402
2018
Q3
$897K Buy
+13,100
New +$843K ﹤0.01% 2480
2017
Q1
Sell
-5,500
Closed -$203K 4224
2016
Q4
$203K Sell
5,500
-6,300
-53% -$225K ﹤0.01% 3747
2016
Q3
$400K Sell
11,800
-6,200
-34% -$217K ﹤0.01% 2839
2016
Q2
$581K Buy
+18,000
New +$551K ﹤0.01% 2085

Other funds holding AVNS

Wolverine Trading's AVNS Position: Q2 2019 in Review

Wolverine Trading sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 4,793 shares — an estimated $205K sold.

Wolverine Trading first reported a position in AVNS in Q2 2016 and held it in 3 quarters. The position peaked at $409K in Q4 2016. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Wolverine Trading reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
  • Wolverine Trading sold 4,793 Avanos Medical shares in Q2 2019, an estimated $205K.
  • Wolverine Trading first reported a position in Avanos Medical in Q2 2016 and held it in 3 quarters.
  • Wolverine Trading's Avanos Medical position peaked at $409K in Q4 2016.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.